Skip to main content
SupplementScience

Chondroitin — Frequently Asked Questions

This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer

Frequently Asked Questions

Should I take chondroitin alone or with glucosamine?

Both approaches have evidence. Chondroitin alone at 800mg daily is effective for OA pain and has been shown non-inferior to celecoxib. Combining with 1,500mg glucosamine sulfate may provide additional benefit, particularly for moderate-to-severe osteoarthritis, as shown in the GAIT trial subgroup analysis.

Why do some studies show chondroitin works and others do not?

Product quality is the main factor. Trials using pharmaceutical-grade chondroitin sulfate (e.g., Condrosulf, Structum) consistently show benefit, while those using unregulated over-the-counter products often do not. Independent testing has found that some OTC products contain less chondroitin than labeled or have degraded molecular weight.

How long does chondroitin take to work?

Symptom relief typically begins within 2-4 weeks, with maximum benefit seen at 3-6 months. Structural benefits (slowing cartilage loss) require at least 1-2 years of continuous use, as demonstrated in the Kahan et al. 2-year trial.

Full Chondroitin Guide

References

  1. (). Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: the study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial. Arthritis & Rheumatism. DOI
  2. (). Pharmaceutical-grade chondroitin sulfate is as effective as celecoxib and superior to placebo in symptomatic knee osteoarthritis: the ChONdroitin versus CElecoxib versus Placebo Trial (CONCEPT). Annals of the Rheumatic Diseases. DOI
  3. (). Chondroitin for osteoarthritis. Cochrane Database of Systematic Reviews. DOI
  4. (). Glucosamine, chondroitin sulfate, and the two in combination for painful knee ostarthritis. New England Journal of Medicine. DOI